Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR vs Placebo and Morphine in Chronic Cancer Pain
NCT00472303Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jul 2007
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 16
01
Overview
Phase 3, randomised, double-blind trial of tapentadol in cancer pain (3 arms), sponsored by Grünenthal GmbH. Primary endpoint: Number of Participants Scored as Responder in Maintenance Phase. Started Jul 2007; status: completed.
02
Drugs
tapentadol
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00472303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00472303.